Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Non-Current Assets for 6 consecutive years, with $844073.0 as the latest value for Q3 2021.

  • Quarterly Non-Current Assets rose 45.11% to $844073.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Sep 2021, up 16.92% year-over-year, with the annual reading at $557240.0 for FY2020, 13.09% down from the prior year.
  • Non-Current Assets for Q3 2021 was $844073.0 at ENDRA Life Sciences, down from $899592.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $899592.0 in Q2 2021, with the low at $211345.0 in Q2 2018.
  • Average Non-Current Assets over 5 years is $446073.9, with a median of $293303.0 recorded in 2018.
  • The sharpest move saw Non-Current Assets dropped 22.32% in 2018, then skyrocketed 146.02% in 2020.
  • Over 5 years, Non-Current Assets stood at $241549.0 in 2017, then increased by 13.12% to $273233.0 in 2018, then soared by 134.66% to $641170.0 in 2019, then decreased by 13.09% to $557240.0 in 2020, then skyrocketed by 51.47% to $844073.0 in 2021.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $844073.0, $899592.0, and $547380.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.